Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial

BACKGROUND: Pancreatic cancer is the fourth largest cause of cancer death in the United States and Europe with over 100,000 deaths per year in Europe alone. The overall 5-year survival ranges from 2–7 % and has hardly improved over the last two decades. Approximately 15 % of all patients have resect...

Descripción completa

Detalles Bibliográficos
Autores principales: Versteijne, Eva, van Eijck, Casper H. J., Punt, Cornelis J. A., Suker, Mustafa, Zwinderman, Aeilko H., Dohmen, Miriam A. C., Groothuis, Karin B. C., Busch, Oliver R. C., Besselink, Marc G. H., de Hingh, Ignace H. J. T., ten Tije, Albert J., Patijn, Gijs A., Bonsing, Bert A., de Vos-Geelen, Judith, Klaase, Joost M., Festen, Sebastiaan, Boerma, Djamila, Erdmann, Joris I., Molenaar, I. Quintus., van der Harst, Erwin, van der Kolk, Marion B., Rasch, Coen R. N., van Tienhoven, Geertjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784417/
https://www.ncbi.nlm.nih.gov/pubmed/26955809
http://dx.doi.org/10.1186/s13063-016-1262-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784417/
https://www.ncbi.nlm.nih.gov/pubmed/26955809
http://dx.doi.org/10.1186/s13063-016-1262-z

Ejemplares similares